AV
MDT icon

ASR Vermogensbeheer’s Medtronic MDT Stock Holding History

ASR Vermogensbeheer’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.8M Sell
99,754
-56,649
-36% -$4.57M 0.08% 228
2026
Q1 		$13.6M Buy
156,403
+3,471
+2% +$333K 0.16% 134
2025
Q4 		$14.7M Sell
152,932
-1,388
-0.9% -$135K 0.17% 122
2025
Q3 		$14.7M Sell
154,320
-742
-0.5% -$68.2K 0.18% 115
2025
Q2 		$13.5M Buy
155,062
+2,989
+2% +$253K 0.18% 113
2025
Q1 		$13.7M Buy
+152,073
New +$13.6M 0.2% 107

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ASR Vermogensbeheer's MDT Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Medtronic (MDT) stake by 36% in Q2 2026, selling an estimated $4.57M and leaving 99,754 shares worth $7.8M. The position accounts for 0.08% of the portfolio, ranked #228.

ASR Vermogensbeheer first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.7M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • ASR Vermogensbeheer held 99,754 shares of Medtronic worth $7.8M as of Q2 2026.
  • ASR Vermogensbeheer sold 56,649 Medtronic shares in Q2 2026, an estimated $4.57M.
  • Medtronic made up 0.08% of ASR Vermogensbeheer's portfolio in Q2 2026, its #228 holding.
  • ASR Vermogensbeheer first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Medtronic position peaked at $14.7M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.